Cite
HARVARD Citation
Brown, J. et al. (2008). A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum. International journal of gynecological cancer. 18 (2), pp. 249-254. [Online].